Researchers collect specimens from advanced or recurrent colorectal cancer (CRC) patients to conduct molecular profiling and establish tumor organoids (PDOs)/ patient-derived xenografts (PDXs). The ai
Previous pre-clinical research has indicated that the intestinal microbiota can potentiate anti-tumor efficacy of capecitabine/5-FU and that 5-FU-based treatment might impact intestinal microbiota com
